Last reviewed · How we verify
an antibody drug conjugate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
an antibody drug conjugate (an antibody drug conjugate) — CSPC ZhongQi Pharmaceutical Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| an antibody drug conjugate TARGET | an antibody drug conjugate | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- an antibody drug conjugate CI watch — RSS
- an antibody drug conjugate CI watch — Atom
- an antibody drug conjugate CI watch — JSON
- an antibody drug conjugate alone — RSS
Cite this brief
Drug Landscape (2026). an antibody drug conjugate — Competitive Intelligence Brief. https://druglandscape.com/ci/an-antibody-drug-conjugate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab